CorMatrix Earns CE Mark Approval for CanGaroo

CorMatrix Cardiovascular has won CE mark approval for its CorMatrix CanGaroo extracellular matrix envelope, the Roswell, Ga.-based company announced Tuesday.

The device is designed for use with cardiac implantable electronic devices, such as pacemakers and implantable cardioverter defibrillators.

CanGaroo nabbed FDA clearance in August 2014. — Anisa Jibrell